Genetic Assays, Inc. Company Profile

02:56 EDT 19th September 2018 | BioPortfolio

To be the leader in the development and commercialization of molecular genetic testing services and products that consistently exceed the needs and expectations of our clients, associates, payers, vendors and shareholders.


4711 Trousdale Drive, Suite 209
United States of America


Phone: 615-781-0709
Fax: 615-781-0766

News Articles [884 Associated News Articles listed on BioPortfolio]

Assays Using ddPCR Quantify DNA Fragments

Optimized droplet digital polymerase chain reaction (ddPCR) assays have been developed that quantify short and long DNA fragments. These assays...

Clearing a xenotransplantation hurdle: detecting infectious agents in pigs

(University of Alabama at Birmingham) In a paper published in Xenotransplantation, Mark Prichard, Ph.D., and colleagues at the University of Alabama at Birmingham have described the development and te...

QIAGEN and Natera Partner to Develop Cutting-Edge Genetic Testing Assays for Use on QIAGEN’s GeneReader NGS System

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a world leader in providing Sample to Insight molecular solutions, and Natera, Inc. (NASDAQ: NTRA), a leading developer of...

Genetic Tests Miss ROS1 Status in Some Advanced NSCLC Cases

Orthogonal assays are recommended for fusion testing to make sure patients get optimal targeted therapy. Medscape Medical News

Natera Names Paul Billings Chief Medical Officer

Paul Billings has been named chief medical officer and senior vice president of medical affairs of Natera (NASDAQ: NTRA). Billings’ experience includes serving as chief medical officer of Life Techn...

Global Protein Assays Market 2018-2022 to Post a CAGR of Over 11% | Technavio

LONDON–(BUSINESS WIRE)–#Assays–The global protein assays market is expected to post a CAGR of more than 11% during the period 2018-2022, according to the latest market research repor...

Poll: Genealogical Curiosity Is a Top Reason for DNA Tests; Privacy a Concern

(NPR) – Beyond the tests that anyone can buy, there is a growing array of genetic tests ordered by doctors — from assays for breast cancer risk to detailed screening of newborns for inherited ...

BAX® System Assays Now Meet New ISO 16140-2 Standard for All AFNOR-Approved Methods

Key European standards organization grants extension to now cover 10 BAX® System PCR assays for Salmonella, E. coli O157:H7, L. monocytogenes, and Genus Listeria

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Alfuzosin hydrochloride [Sun Pharma Global FZE]

These highlights do not include all the information needed to use alfuzosin hydrochloride safely and effectively. See full prescribing information for alfuzosin hydrochloride extended-release tablets....

PubMed Articles [1936 Associated PubMed Articles listed on BioPortfolio]

Design tools for MPRA experiments.

Genetic reporter assays are a convenient, relatively inexpensive method for studying the regulation of gene expression. Massively Parallel Reporter Assays (MPRA) are high-throughput functionalization ...

Genetic testing in children and adolescents with intellectual disability.

Investigation for genetic causes of intellectual disability has advanced rapidly in recent years. We review the assessment of copy number variants (CNVs) and the use of next-generation sequencing base...

Optimal HTS fingerprints definitions by using a desirability function and a genetic algorithm.

Compound biological fingerprints built on data from high throughput screening (HTS) campaigns, or HTS fingerprints, are a novel cheminformatics method of representing compounds by integrating chemical...

Genotoxicity assessment of nanomaterials: recommendations on best practices, assays and methods.

Nanomaterials (NMs) present unique challenges in safety evaluation. An international working group, the Genetic Toxicology Technical Committee of the International Life Sciences Institute's Health and...

Quantifying autophagy using novel LC3B and p62 TR-FRET assays.

Autophagy is a cellular mechanism that can generate energy for cells or clear misfolded or aggregated proteins, and upregulating this process has been proposed as a therapeutic approach for neurodegen...

Clinical Trials [2335 Associated Clinical Trials listed on BioPortfolio]

Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation

In patients with non-valvular atrial fibrillation treated with dabigatran etexilate, the level of adherence will be measured using a questionnaire, the Danish National Prescription Registr...

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

The purposes of this study are: - To determine the accuracy of commercially available serologic assays in diagnosing patients with herpes simplex virus type 2 (HSV-2); - ...

T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus

Type 1 diabetes is a condition that is caused in part by an abnormality of the immune system which occurs when T cells, which are part of the immune system, damage the insulin secreting ce...

Fertility in Healthy Premenopausal Women

The study objectives are described below: 1. Obtain serum specimens collected for one ovulatory cycle or a maximum of 33 days, but not to exceed a total of 550 ml of whole blood pe...

A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments

The overall goal of this study is to determine the feasibility and the variability of several biomarker assays in normal subjects that are relevant to tumor biology and novel anti-cancer t...

Companies [355 Associated Companies listed on BioPortfolio]

Genetic Analysis

Genetic Analysis has developed and launched the first gene-based routine test for the mapping and diagnosis of diseases related to dysbiosis and imbalances in the bacteria in the ...


CENTOGENE unlocks the power of genetic insights to improve the quality of life of patients with rare genetic diseases. We achieve this through knowledge created by our worldwide d...

Color Genomics

Color Genomics provides a high-quality, physician-ordered, genetic test for 19 genes related to breast and ovarian cancer risk, including BRCA1 and BRCA2. The Color Test includes ...

Genetic Technologies Limited

Genetic Technologies was an early pioneer in recognizing important new applications for “non-coding” DNA (Deoxyribonucleic Acid). The Company has since been granted pate...

Natera, Inc.

Natera is a genetic testing company that has developed a proprietary bioinformatics technology (Parental Support) to deliver accurate and comprehensive high throughput testing for...

More Information about "Genetic Assays, Inc." on BioPortfolio

We have published hundreds of Genetic Assays, Inc. news stories on BioPortfolio along with dozens of Genetic Assays, Inc. Clinical Trials and PubMed Articles about Genetic Assays, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genetic Assays, Inc. Companies in our database. You can also find out about relevant Genetic Assays, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record